Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Derek Lamb

Oral & Maxillofacial Surgery Scottsdale, AZ Doctor of Dentistry

NPI 1063485829 CMS profile 184682

3501 N Scottsdale Rd Ste 226, Scottsdale, AZ 85251

Open in the dashboard

General payments

$4,918

79 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Derek Lamb of Scottsdale, AZ is reported in the CMS Open Payments database as having received $4,918 across 79 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $290 3
2024 General $481 7
2023 General $237 9
2022 General $163 5
2021 General $327 8
2020 General $769 13
2019 General $2,651 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derek Lamb
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Derek Lamb were reported at $290. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Derek Lamb Oral & Maxillofacial Surgery median Middle half National median
2019 $2,651 $178 $56–$584 $163
2020 $769 $106 $38–$316 $114
2021 $327 $165 $57–$511 $132
2022 $163 $173 $63–$494 $149
2023 $237 $184 $62–$521 $160
2024 $481 $197 $65–$603 $164
2025 $290 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nobel Biocare USA $2,244 21 payments
  2. Straumann USA LLC $1,303 34 payments
  3. ACE Surgical Supply Co., Inc. $525 6 payments
  4. Geistlich Pharma, North America, Inc. $271 3 payments
  5. BioHorizons Implant Systems Inc. $179 2 payments
  6. Keystone Dental Inc. $168 2 payments
  7. Kowa Pharmaceuticals America, Inc. $87 4 payments
  8. Carestream Dental, LLC $50 3 payments
  9. Southern Anesthesia & Surgical, Inc $44 1 payment
  10. Dentsply Sirona Inc $17 1 payment
  11. Other $31 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,007 74 payments
  2. Travel and Lodging $1,536 1 payment
  3. Entertainment $228 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $102 1 payment
  5. Gift $45 1 payment
Products named General payments · program years 2019–2025
  1. NOBELACTIVE Dental implant $1,835 10 payments
  2. NOBELPARALLEL $1,835 10 payments
  3. BONE GRAFTING & REGENERATIVE $383 4 payments
  4. NOBELACTIVE Dental implant $200 5 payments
  5. BIOHORIZONS Implant Dentistry $179 2 payments
  6. BIOHORIZONS Implant Dentistry $179 2 payments
  7. BIOHORIZONS Implant Dentistry $179 2 payments
  8. BIOHORIZONS Implant Dentistry $179 2 payments
  9. BIOHORIZONS Implant Dentistry $179 2 payments
  10. NOBELPROCERA $174 7 payments
  11. Other $931 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

1,385

Median for Oral & Maxillofacial Surgery: 284

Drug cost

$5,893

Median for Oral & Maxillofacial Surgery: $1,067

Branded share of claims

28.3%

Median for Oral & Maxillofacial Surgery: 17.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 271 $1,552
Chlorhexidine Gluconate Generic 395 $1,519
Amoxicillin Generic 408 $1,056
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 80 $465
Clindamycin Hcl Generic 55 $445
Ibuprofen Generic 74 $238
Acetaminophen-Codeine Acetaminophen With Codeine Brand 41 $198
Methylprednisolone Generic 25 $175
Triamcinolone Acetonide Generic 11 $170
Azithromycin Generic 14 $56

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 600 Part D prescribers listed as Oral & Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Records

79 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record